ArticleAIDS and behavior2026
Prevention Effective Practice: Development and Preliminary Evaluation of a Proposed Composite Outcome for Status-Neutral HIV Prevention Research.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Status-neutral HIV prevention frameworks require outcome measures to evaluate prevention and care strategies across populations without separate endpoints for people living with and without HIV. We developed and conducted a preliminary evaluation of a proposed composite outcome measure, "prevention effective practice," integrating behavioral and biomedical prevention practices into a single binary outcome. Using longitudinal data from 392 transgender women not living with HIV in São Paulo, Brazil, we assessed whether prevention effective practice predicted subsequent HIV seroconversion. Prevention effective practice incorporated sufficient PrEP use, condom use, abstinence from sex, and absence of injection risk. Despite the small number of seroconversions (n = 11), prevention effective practice demonstrated preliminary predictive utility, with a Brier score of 0.0030, sensitivity of 0.59 (95%CI 0.56, 0.62), and specificity of 0.70 (95%CI 0.41, 0.99). These findings support further evaluation of prevention effective practice as a proposed status-neutral outcome measure, including validation among people living with HIV.
Indexed as
Identifiers
42814383What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.